Prestige Biopharma Successfully Concludes 'Prestige Symposium' on Aging
Prestige Biopharma IDC, the drug research and development subsidiary of Prestige Biopharma, announced on the 8th that it had successfully concluded the '2026 Prestige Symposium'.
Attendees are taking a commemorative photo at the '2026 Prestige Symposium' held on the 4th / Photo by Prestige Biopharma
View original imageThe symposium, which was held on the 4th, focused on the theme of 'Mechanisms of Aging and Recent Trends in Aging-Related Diseases'. The event aimed to provide a comprehensive overview that connected fundamental research into the mechanisms of aging with therapeutic development strategies, serving as a venue to share the latest research findings and treatment strategies.
In the keynote speech, Dr. Arthur Levine introduced the advances and potential of oligonucleotide therapeutics and presented new approaches that could be applied in the treatment of aging-related diseases. Subsequent sessions featured presentations by Professor Jung Hae-Young of Pusan National University, Professor Lee Seung-Jae of KAIST, Professor Yoon Jin-Ho of Dong-A University, Lee Ho-Young, senior researcher at Syntekabio, Professor Kang Chan-Hee of Seoul National University, Professor Ryu Dong-Ryeol of Gwangju Institute of Science and Technology, Professor Lee Jae-Won of Pusan National University, and Kwon Ki-Seon, CEO of Aventi. They shared their research results related to aging and discussed strategies for research and drug development.
Hot Picks Today
"Even on the Way to Work, There Are Lines at the 'Yellow Sign'... Mega MGC Coffee Achieves KRW 400 Million Sales Per Store with KRW 1,500 Coffee"
- "Can Hair Loss Now Be Treated by Injection? New Drug Race to Reactivate Dormant Follicles Heats Up K-Bio"
- "It’s a Place I Frequented"... Before Body Found in Cafe Freezer, 'Normal Operations Resume Tomorrow' Shocks Netizens
- Minister Park Hongkeun Says "Kim Seungwon Unfairly Accused"...On Yong Hyein: "Excessive Ambition Against Public Sentiment"
- "My Husband Went to the Han River Every Night"... Private Investigator Reveals Hidden Stories Behind Running Clubs
Ko Sang-Seok, CEO of Prestige Biopharma IDC, stated, "This symposium was significant in that it brought together a wide range of research achievements connecting the fundamental mechanisms of aging with the actual development of new drugs, and allowed us to discuss new therapeutic possibilities." He added, "We will continue to expand exchanges with domestic and international researchers and industry in order to strengthen the collaborative foundation so that research achievements in aging-related diseases can lead to innovative drug development."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
